Treatment for heart valve disease ranges from regular monitoring and medication to surgical repair or replacement, depending on how severe the condition is and whether it’s causing symptoms. Many people live with mild valve disease for years with no intervention beyond periodic checkups, while others eventually need a procedure to fix or replace the affected valve.
Active Monitoring for Mild Disease
Not everyone with heart valve disease needs immediate treatment. When the condition is mild and not causing symptoms, the standard approach is watchful waiting with regular imaging to track how the valve is functioning over time. Current guidelines from the American College of Cardiology and the American Heart Association recommend repeat echocardiograms (ultrasounds of the heart) every 3 to 5 years for mild disease, every 1 to 2 years for moderate disease, and every 6 to 12 months for severe disease. These intervals help catch the point where the valve has deteriorated enough to warrant action, ideally before the heart muscle itself starts to weaken.
During this phase, your cardiologist will ask about new or worsening symptoms like shortness of breath, chest tightness, fatigue, or dizziness. If you’re physically active, yearly exercise testing may be recommended to make sure your effort tolerance matches your activity level and that your blood pressure responds normally during exertion.
Medications That Manage Symptoms
No medication can fix a damaged heart valve, but several drug classes can ease the strain on your heart and reduce symptoms while you and your doctor decide on next steps, or if surgery isn’t an option.
- Diuretics help remove excess fluid, relieving shortness of breath and swelling. In aortic stenosis (a narrowed aortic valve), they’re used cautiously because pulling too much fluid can reduce the amount of blood the heart pumps with each beat.
- ACE inhibitors lower blood pressure and may help reduce scarring in the heart muscle, which is particularly useful when aortic stenosis has started to thicken the walls of the heart’s main pumping chamber.
- Beta-blockers slow the heart rate, giving blood more time to flow through a narrowed valve. In rheumatic mitral stenosis, for example, a slower rate lengthens the filling period between heartbeats and lowers pressure in the upper chamber of the heart.
These medications are part of standard heart failure management when severe valve disease has weakened the heart’s pumping ability and a procedure has been declined or isn’t feasible.
Valve Repair vs. Replacement
When valve disease progresses to the point of causing symptoms or measurable heart damage, a procedure to repair or replace the valve becomes the primary treatment. Surgeons generally recommend repair when it’s possible because it preserves your own valve tissue, lowers infection risk, and often allows the heart to function more naturally afterward. Repair works well for certain types of leaky (regurgitant) valves, especially the mitral valve, but isn’t always feasible for valves that have become stiff and calcified.
When the valve is too damaged to repair, replacement is the next step. This involves removing the diseased valve and implanting either a mechanical or a biological (tissue) valve. The choice between the two is one of the most important decisions in the process.
Mechanical Valves
Mechanical valves are made from durable synthetic materials and typically last for the rest of a person’s life. The tradeoff is that they require lifelong use of a blood thinner (warfarin) to prevent clots from forming on the valve’s surface. This means regular blood tests to keep your clotting level in a specific target range. For a mechanical valve in the aortic position, the target is an INR of 2.0 to 3.0. For a mechanical mitral valve, the target is slightly higher at 2.5 to 3.5. Staying in range requires consistent medication timing, dietary awareness around vitamin K, and ongoing lab work.
Tissue (Biological) Valves
Tissue valves are typically made from pig or cow heart tissue, or occasionally from donated human tissue. They don’t usually require long-term blood thinners, which makes daily life simpler. The downside is durability: tissue valves last about 15 years on average before they begin to wear out, meaning younger patients may eventually need a second procedure. For this reason, mechanical valves are sometimes favored in younger patients willing to commit to blood thinners, while tissue valves are often preferred in older adults.
Minimally Invasive and Catheter-Based Options
Traditional valve surgery requires opening the chest through the breastbone. Minimally invasive approaches use smaller incisions between the ribs, and when performed at experienced centers, produce results comparable to open-heart surgery. But the biggest shift in recent years has been the growth of catheter-based procedures, which avoid chest incisions entirely by threading devices through blood vessels, usually starting from the groin.
TAVR for Aortic Stenosis
Transcatheter aortic valve replacement, or TAVR, is the most established catheter-based option. A collapsible replacement valve is guided through an artery and expanded inside the diseased aortic valve. TAVR was originally reserved for patients too frail for open surgery, but it’s now approved for patients across all risk levels with symptomatic aortic stenosis.
Outcomes are comparable to traditional surgery in several key measures. Thirty-day and one-year mortality rates show no significant difference between TAVR and open surgery. Stroke rates at 30 days are also similar. Where the two diverge is in the type of complications. TAVR carries a higher rate of vascular complications (damage to blood vessels at the insertion site) and a greater likelihood of needing a permanent pacemaker afterward. Open surgery, on the other hand, is associated with more major bleeding, acute kidney injury, and new episodes of irregular heart rhythm. For many patients, the shorter recovery time and avoidance of a chest incision make TAVR the preferred choice.
The procedure requires evaluation by a “heart team” that includes both a cardiac surgeon and an interventional cardiologist. Both independently assess whether you’re a better candidate for TAVR, open surgery, or medical therapy alone.
TEER for Mitral Regurgitation
For a leaky mitral valve, transcatheter edge-to-edge repair (TEER) offers a catheter-based alternative to open surgery. A small clip is threaded to the heart and used to pinch the mitral valve’s two leaflets together, reducing the backward flow of blood. This approach is typically considered for patients whose surgical risk is too high for traditional mitral valve repair.
Newer Tricuspid Valve Devices
The tricuspid valve, located on the right side of the heart, has historically had fewer treatment options. Two catheter-based devices recently received FDA approval for tricuspid regurgitation (a leaky tricuspid valve). One is a replacement system and the other uses a clip similar to TEER for the mitral valve. Early data on the replacement system showed that nearly 99% of recipients had their leak reduced to moderate or less at six months, with meaningful improvements in symptoms and daily function compared to medication alone. These devices are still in early rollout, and coverage by insurance may require additional evidence from ongoing studies, but they represent a significant new option for patients who previously had few alternatives.
Recovery After Valve Surgery
Recovery timelines vary based on the type of procedure. After traditional open-heart surgery for mitral valve repair, most people spend about a week in the hospital. Full recovery, meaning a return to normal daily activities, takes four to eight weeks. During that time, your care team will give specific guidance on when you can safely drive, lift heavy objects, and begin gentle exercise like walking. Cardiac rehabilitation, a supervised exercise and education program, is commonly recommended to help rebuild strength and confidence.
Catheter-based procedures like TAVR typically involve a much shorter hospital stay, often just one to three days, with faster recovery overall. Some patients are walking the same day and resume light activities within a week or two.
Exercise and Physical Activity
Staying active is important with valve disease, but the type and intensity of exercise that’s safe depends on severity. People with mild to moderate disease can generally participate in most physical activities, though yearly evaluation with an echocardiogram is recommended to confirm that exercise tolerance matches the activity level. Exercise stress testing can help determine whether your blood pressure and heart rhythm respond normally under exertion.
Severe symptomatic valve disease is a different situation. Vigorous or competitive exercise is typically not recommended until the valve has been repaired or replaced. After a successful procedure and full recovery, many people return to an active lifestyle, including regular exercise.